# Daiichi Sankyo Co., Ltd. Odawara Plant – FDA Inspection, Jan 25, 2019

Source: https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-co-ltd-odawara-plant/59630dec-a3a1-4c89-a348-2502b37755dc
Source feed: FDA_Inspections

> FDA inspection 1081871 of Daiichi Sankyo Co., Ltd. Odawara Plant, January 25, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1081871
- Company Name: Daiichi Sankyo Co., Ltd. Odawara Plant
- Inspection Date: 2019-01-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 971682 - 2016-04-15
- FDA Inspection 891670 - 2014-06-20

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/zachary-l-stamm/b729fab9-4d31-4c70-b5b3-e8b6207769c6)

Company: https://www.keypedia.com/companies/daiichi-sankyo-co-ltd-odawara-plant/83cd6ae3-96fe-46bb-85a7-2aee947e573b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c